Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
1.440
-0.040 (-2.70%)
At close: Oct 9, 2025, 4:00 PM EDT
1.440
0.00 (0.00%)
After-hours: Oct 9, 2025, 4:00 PM EDT
Zynex Market Cap
Zynex has a market cap or net worth of $43.63 million as of October 9, 2025. Its market cap has decreased by -82.78% in one year.
Market Cap
43.63M
Enterprise Value
99.76M
1-Year Change
-82.78%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since February 12, 2019, Zynex's market cap has decreased from $154.40M to $43.63M, a decrease of -71.74%. That is a compound annual growth rate of -17.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 44.80M | -82.44% |
| Dec 31, 2024 | 255.10M | -30.90% |
| Dec 29, 2023 | 369.20M | -29.14% |
| Dec 30, 2022 | 521.00M | 50.23% |
| Dec 31, 2021 | 346.80M | -25.83% |
| Dec 31, 2020 | 467.60M | 81.45% |
| Dec 31, 2019 | 257.70M | 66.90% |
| Feb 12, 2019 | 154.40M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 757.36B |
| Johnson & Johnson | 454.91B |
| AbbVie | 411.31B |
| UnitedHealth Group | 329.36B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 261.01B |
| Novartis AG | 255.35B |
| Abbott Laboratories | 231.52B |